Advanced search
Publication Cover
Blood and Lymphatic Cancer: Targets and Therapy Volume 9, 2019 - Issue
Submit an article Journal homepage
117
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

Fangwen Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Ling Li1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Lei Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xin Li1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xiaorui Fu1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xinhua Wang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Jingjing Wu1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Zhenchang Sun1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Fei Kong1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Liangliang Ren1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
&
Mingzhi Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
 show all
Pages 33-43 | Published online: 19 Aug 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (5)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.